Strikingly, breast cancers exhibiting elevated CDK18 mRNA expression were associated with a poorer response to the commonly used replication stress-inducing chemotherapeutic agents 5-FU, cyclophosphamide and methotrexate (n = 416, Log Rank -3.901, p = 0.04; Figure 1C). Here, CDK18 is linked to breast carcinoma.